MedTrace Logo

Dysregulated Tyrosine Kinase Signaling in Leukemia

NCT00277056 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-02-07

No results posted yet for this study

Summary

Dysregulated Tyrosine Kinase Signaling in Leukemia

Conditions

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Ian Rabinowitz, MD · University of New Mexico

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-31
Primary Completion
2005-10-31
Completion
2005-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00277056 on ClinicalTrials.gov